Literature DB >> 2454215

Cytomegalovirus detection by nonisotopic in situ DNA hybridization and viral antigen immunostaining using a two-color technique.

R A Wolber1, R V Lloyd.   

Abstract

Rapid methods of specific viral diagnosis in formalin fixed, paraffin embedded tissues include identification of viral incusions in routinely stained histologic sections, immunologic staining of viral antigens, and in situ nucleic acid hybridization. To correlate in situ hybridization with immunologic detection methods, sequential two-color staining was used on tissues from 12 patients, each containing characteristic cytomegalovirus (CMV) inclusions, using a biotinylated CMV DNA probe in an avidin-alkaline phosphatase-linked reaction followed by avidin-biotin complex immunoperoxidase staining of CMV antigen. CMV genetic material was seen in all 17 tissues. CMV antigen was detected in 11 of 17 tissues (65%). The DNA hybridization technique provided more intense staining, detected greater numbers of inclusions, and had less background staining than the immunoperoxidase technique. The alkaline phosphatase reaction product was stable through subsequent immunostaining steps, and immunologic reactivity of CMV antigen was not significantly reduced by prior hybridization steps. CMV DNA probe was localized predominantly within cell nuclei, while CMV antigen immunostaining was predominantly cytoplasmic. It was concluded that sequential in situ hybridization and immunocytochemistry can be performed on standard histologic sections. Furthermore, it is likely that the majority of CMV nucleic acid detected by this tissue hybridization technique is unencapsidated, intranuclear viral DNA and not DNA contained within complete CMV nucleocapsids.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454215     DOI: 10.1016/s0046-8177(88)80182-5

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Simultaneous in situ genotyping and phenotyping of human papillomavirus cervical lesions: comparative sensitivity and specificity.

Authors:  A K Graham; C S Herrington; O McGee J
Journal:  J Clin Pathol       Date:  1991-02       Impact factor: 3.411

Review 2.  Practical suggestions for successful immunoenzyme double-staining experiments.

Authors:  C M van der Loos; A E Becker; J J van den Oord
Journal:  Histochem J       Date:  1993-01

3.  Simultaneous application of in situ DNA hybridization and immunohistochemistry on one tissue section.

Authors:  C M Van der Loos; H H Volkers; R Rook; F M Van den Berg; H J Houthoff
Journal:  Histochem J       Date:  1989-05

4.  Identification of cytomegalovirus infection in acquired immunodeficiency syndrome.

Authors:  T Tomita; M Chiga; M Lenahan; N Balachandran
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  A one-day double-labelling technique for tissue specimens: immunogold-silver staining for in situ hybridization combined with alkaline phosphatase-anti-alkaline phosphatase (APAAP) immunohistochemistry for antigens.

Authors:  U Müller-Ladner; J Kriegsmann; R E Gay; S Gay
Journal:  Histochem J       Date:  1996-02

6.  Interphase cytogenetics using biotin and digoxigenin labelled probes II: Simultaneous differential detection of human and papilloma virus nucleic acids in individual nuclei.

Authors:  C S Herrington; J Burns; A K Graham; B Bhatt; J O McGee
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

7.  Localization of the human cytomegalovirus 2.7-kb major early beta-gene transcripts by RNA in situ hybridization in permissive and nonpermissive infections.

Authors:  T C Wu; W A Lee; M C Pizzorno; W C Au; Y J Chan; R H Hruban; G M Hutchins; G S Hayward
Journal:  Am J Pathol       Date:  1992-11       Impact factor: 4.307

8.  Detection of human papillomavirus in cervical scrapings by in situ hybridization and the polymerase chain reaction in relation to cytology.

Authors:  M Ramael; K Segers; N Pannemans; F Wesling; E Van Marck
Journal:  Histochem J       Date:  1995-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.